ArticleFrontiers in immunology2025
Integrated analysis of the relationship between metabolic pathways and immune infiltration in rheumatoid arthritis.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovitis and systemic inflammation. Growing evidence highlights the critical role of metabolic dysregulation in RA pathogenesis, particularly through its impact on immune infiltration. However, the relationship between metabolic pathways and immune infiltration in RA remains unclear. Methods: This study integrated RNA-Seq data and clinical information from the GEO database to investigate the activity of seven major metabolic pathways and immune cell infiltration in RA patients. A co-expression network associated with RA was constructed using WGCNA, and key hub genes were identified using the LASSO logistic regression. A LASSO-based diagnostic model was then developed and validated across multiple independent datasets. To investigate the subcellular localization of the hub genes, scRNA-seq analysis was performed using publicly available datasets. Further correlation analyses were conducted to evaluate their involvement in immune infiltration and related metabolic processes. Additionally, the role of a key risk gene, COX7C, in RA was investigated through Results: Three dysregulated metabolic pathways, including amino acid, energy, and TCA cycle, were found to distinguish RA from healthy controls. A co-expression network strongly correlated with the TCA cycle was extracted. Then, eleven key hub genes were identified and appeared to bridge metabolic reprogramming and immune dysregulation. The LASSO model incorporating these genes showed robust diagnostic performance and correlated with RA disease severity. The scRNA-seq analysis revealed dysregulation of amino acid, lipid, carbohydrate, nucleotide, and TCA cycle metabolism in PBMCs from RA patients. COX7C was positively associated with amino acid and TCA cycle pathways in both PBMCs and fibroblasts, and was significantly upregulated in RA synovial tissue Conclusion: Metabolic pathways, particularly the TCA cycle, play a critical role in the pathogenesis of RA. Eleven key hub genes were identified as being involved in metabolic reprogramming associated with immune infiltration, and the LASSO model incorporating these genes demonstrated strong diagnostic potential for RA. Notably, COX7C might contribute to RA progression by dysregulating cellular metabolic processes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.